Primary tabs
Andrew is a registered nurse of 32 years, with more than 20 years experience in the natural medicine industry. As a Senior Educator at with one of Australia's leading nutraceutical companies, he has the responsibility of explaining complex biochemical processes using simple analogies to help individuals understand how they apply to wellbeing. He delights in researching biochemistry, pathophysiology as well as nutritional and herbal medicines. His favourite patient interests include: gastroenterology, immunology and oncology. He has lectured to nutritionists, naturopaths, nurses, dietitians, pharmacists and doctors Australia-wide.
Researchers are finding that different gut microbes can even influence the way medicines work in our bodies. The problem is that it’s both good and bad news. But what all of the research points to is that we’d better look after our microbes.
Research shows that sea buckthorn is a safe and effective option for post-menopausal vaginal atrophy.
You may be blissfully unaware of the issue of herbal adulteration in the natural medicine industry. In this article, Andrew puts this issue under the microscope.
With emerging evidence that vitamin D may mediate immunomodulatory effects in patients with IBD, this study aimed to assess a specific supplementation regimen of vitamin D to increase serum 25(OH)D to 100-125nmol/L, and to evaluate change in disease activity.
Research shows we emit a microbial cloud into our surroundings that is as unique as a fingerprint.
Dysbiotic gut bacteria have an impact on paracetamol and other drugs' safety lending credence to the clinical relevance of conducting Liver Detoxification Profiles in patients.
Taking a look at research that acutely highlights the shortcomings of taking a reductionist view to the application of single strain or species probiotic therapy as an exclusive approach in clinical practice.
Zinc carnosine has been quoted as being three times more effective than the singular ingredients, and has greater ulcer healing effects than cimetidine, a first generation anti-ulcer drug with significant drug-drug interactions.